29.05.2013 • News

Brenntag Does Not Agree with Decision of French Competition Authority

Brenntag SA, a French subsidiary of Brenntag AG which represented about 4% of the Group's sales in 2012, has been informed today by the French Competition Authority (FCA) of the fine of €48 million imposed on Brenntag SA jointly with a further party regarding infringements to competition law, from 1998 to 2005 in France.

Brenntag SA does not agree with the legal qualification of the facts and the calculation of the fine of the FCA and will consider an appeal.

Brenntag France applied for leniency in 2006 and has actively contributed to the investigation and provided all information and proofs working closely together with the FCA regarding the clarification of the facts.

Brenntag Group is committed to free competition and does not tolerate any infringements of antitrust law. Brenntag regularly conducts substantial training programs and has comprehensive policies in place in order to strengthen this commitment.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read